nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—AVPR2—G alpha (s) signalling events—P2RY11—narcolepsy	0.0245	0.0245	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0184	0.0184	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0184	0.0184	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0182	0.0182	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0182	0.0182	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.018	0.018	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.018	0.018	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.0178	0.0178	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0165	0.0165	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0165	0.0165	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0159	0.0159	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—HCRT—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0149	0.0149	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0148	0.0148	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0142	0.0142	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0142	0.0142	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0141	0.0141	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0141	0.0141	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0135	0.0135	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—PENK—narcolepsy	0.0133	0.0133	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—PENK—narcolepsy	0.0132	0.0132	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0122	0.0122	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0122	0.0122	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0121	0.0121	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0121	0.0121	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—NPS—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—TRH—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—TRH—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—TRH—narcolepsy	0.0112	0.0112	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.01	0.01	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00993	0.00993	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00928	0.00928	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00928	0.00928	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HCRTR1—narcolepsy	0.00921	0.00921	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HCRTR2—narcolepsy	0.00921	0.00921	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—P2RY11—narcolepsy	0.00896	0.00896	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00892	0.00892	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—P2RY11—narcolepsy	0.0089	0.0089	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00885	0.00885	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—NPS—narcolepsy	0.00832	0.00832	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00832	0.00832	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00821	0.00821	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—NPS—narcolepsy	0.00821	0.00821	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00815	0.00815	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—NPS—narcolepsy	0.00815	0.00815	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00776	0.00776	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0077	0.0077	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HCRT—narcolepsy	0.00762	0.00762	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00758	0.00758	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HCRT—narcolepsy	0.00756	0.00756	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00753	0.00753	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00744	0.00744	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00744	0.00744	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—PENK—narcolepsy	0.00679	0.00679	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—PENK—narcolepsy	0.00674	0.00674	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00665	0.00665	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0066	0.0066	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—TRH—narcolepsy	0.00577	0.00577	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—TRH—narcolepsy	0.00573	0.00573	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00551	0.00551	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00551	0.00551	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00547	0.00547	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00547	0.00547	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00524	0.00524	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00524	0.00524	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HCRTR2—narcolepsy	0.0052	0.0052	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HCRTR1—narcolepsy	0.0052	0.0052	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00506	0.00506	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HRH3—narcolepsy	0.00506	0.00506	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—P2RY11—narcolepsy	0.00503	0.00503	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HRH3—narcolepsy	0.00503	0.00503	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.005	0.005	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00476	0.00476	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00476	0.00476	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HCRTR2—narcolepsy	0.00473	0.00473	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HCRTR1—narcolepsy	0.00473	0.00473	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—P2RY11—narcolepsy	0.0046	0.0046	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—P2RY11—narcolepsy	0.00456	0.00456	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00448	0.00448	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HCRT—narcolepsy	0.00431	0.00431	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HCRT—narcolepsy	0.00427	0.00427	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—TAC1—narcolepsy	0.00419	0.00419	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—NPS—narcolepsy	0.00419	0.00419	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—TAC1—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—NPS—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HCRT—narcolepsy	0.00391	0.00391	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HCRT—narcolepsy	0.00388	0.00388	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00384	0.00384	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PENK—narcolepsy	0.00384	0.00384	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PENK—narcolepsy	0.00381	0.00381	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PENK—narcolepsy	0.00348	0.00348	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PENK—narcolepsy	0.00346	0.00346	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00331	0.00331	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—TRH—narcolepsy	0.00326	0.00326	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—TRH—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TRH—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TRH—narcolepsy	0.00294	0.00294	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HRH3—narcolepsy	0.00286	0.00286	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HRH3—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HCRTR1—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HCRTR2—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HCRTR2—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HCRTR1—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—P2RY11—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—P2RY11—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRH3—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRH3—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR2A—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HTR2A—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—TAC1—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—NPS—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—NPS—narcolepsy	0.00235	0.00235	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—TAC1—narcolepsy	0.00235	0.00235	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HCRT—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HCRT—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00226	0.00226	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TAC1—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—NPS—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—NPS—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TAC1—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PENK—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PENK—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TRH—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TRH—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRH3—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRH3—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR2A—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR2A—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR2A—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR2A—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NPS—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TAC1—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NPS—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TAC1—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000811	0.000811	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR2A—narcolepsy	0.000765	0.000765	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR2A—narcolepsy	0.00076	0.00076	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CHKB—narcolepsy	0.000723	0.000723	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CPT1B—narcolepsy	0.000491	0.000491	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CHKB—narcolepsy	0.000445	0.000445	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.0004	0.0004	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000303	0.000303	CbGpPWpGaD
